Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(6/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(6/week)
News
United States
(507/week)
Manufacturing
(335/week)
Energy
(278/week)
Technology
(347/week)
Other Energy
(240/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Oncolytics Biotech® Inc.
Feb 23, 2021
Oncolytics Biotech® Reports Preclinical Data Demonstrating the Synergistic Anti-cancer Activity of Pelareorep Combined with CAR T Cell Therapy in Solid Tumors
Dec 09, 2020
Oncolytics and SOLTI Report Clinical Synergy of Pelareorep with Checkpoint Inhibitors at the 2020 San Antonio Breast Cancer Symposium
Nov 19, 2020
Oncolytics Biotech® Announces Positive Clinical Results Against Glioblastoma Multiforme at the 2020 Society of Neuro-Oncology Annual Meeting
Nov 09, 2020
Oncolytics Biotech® and SOLTI Present Clinical Breast Cancer Data Highlighting Pelareorep-Induced Anti-Tumor T Cell Responses at The Society for Immunotherapy of Cancer Annual Meeting
Nov 09, 2020
Oncolytics Biotech® Announces Abstract Publication and Upcoming Oral Presentation at the 2020 Society of Neuro-Oncology Annual Meeting
Oct 27, 2020
Oncolytics Biotech® Collaborates with Roche and AIO to Initiate a Phase 1/2 Gastrointestinal Cancer Trial Combining Pelareorep with Roche's Anti-PD-L1 Checkpoint Inhibitor
Oct 07, 2020
Oncolytics Biotech® to Participate in BIO Investor Forum Digital
Sep 01, 2020
Oncolytics Biotech® Announces Upcoming Presentations at Investor Conferences
Aug 26, 2020
Oncolytics Biotech® Doses First Patient in Phase 2 IRENE Study Evaluating Pelareorep-anti-PD-1 Combination Treatment in Triple-Negative Breast Cancer
Aug 10, 2020
Oncolytics Biotech® to Participate in Virtual Fireside Chat at the Canaccord Genuity 40th Annual Growth Conference
Aug 04, 2020
Oncolytics Biotech® Reports 2020 Second Quarter Financial Results and Operational Highlights
Jun 25, 2020
Oncolytics Biotech® Announces Investigator Sponsored Phase 2 Trial Evaluating Pelareorep-anti-PD-1 Combination Treatment in Triple-Negative Breast Cancer
Jun 23, 2020
Oncolytics Biotech® Doses First Patient in Phase 2 BRACELET-1 Study Evaluating Pelareorep-Based Combination Therapies in Metastatic Breast Cancer
Jun 04, 2020
Oncolytics Biotech® Provides Recap of Key Opinion Leader Call Highlighting the Induction of Rapid and Persistent Immune Responses With Systemic Pelareorep Treatment
May 13, 2020
Oncolytics Biotech® to Present at the RBC Global Healthcare Conference
Apr 30, 2020
Oncolytics Biotech® Announces Changes to Annual General Meeting
Apr 17, 2020
Oncolytics Biotech® Updates Clinical Development and Operations Activities During the COVID-19 Pandemic
Apr 02, 2020
Oncolytics Biotech® Announces Publication of Pelareorep's Clinical Benefit Against KRAS Mutated Colorectal Cancer
Mar 24, 2020
Oncolytics Biotech® Announces Favourable AWARE-1 Safety Update
Mar 05, 2020
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Highlights
Latest News
Apr 19, 2024
Construction Equipment Global Strategic Business Report 2024: Market to Reach $248.5 Billion by 2030 - Focus...
Apr 19, 2024
New Jersey Natural Gas to Reduce Fleet Emissions with Neste MY Renewable Diesel
Apr 19, 2024
VulnCheck Closes $7.95 Million in Seed Funding to Accelerate Momentum Amid Growing Demand for its Next-...
Apr 19, 2024
AEVEX Aerospace to Debut Atlas Loitering Munition at 2024 Army Aviation Mission Solutions Summit
Apr 19, 2024
Solar Sector Sees $8.1 Billion in Corporate Funding in Q1 2024, Reports Mercom Capital Group
Apr 19, 2024
US Consumers’ 2024 Sustainability Score Declines and Lags the Global Average, According to New Report
Apr 19, 2024
Kontoor Brands Declares Quarterly Dividend
Apr 19, 2024
American Water Honored as a 2024 VETS Indexes 5 Star Employer
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events